Abstract
Chronic inflammation is the cause of various diseases such as rheumatoid arthritis and asthma, with a large number of people suffering from them. There have been many reports that even link cancer to inflammation, so the development of sophisticated and powerful drugs continues to be in demand. Here we demonstrate that the methanol extract of Lecania gerlachei (LGME), a lichen member found in the extreme Antarctic environment, exhibits anti-inflammatory activities. Treatment of lipopoly-saccharide (LPS) stimulated Raw 264.7 murine macrophage cells with LGME reduced nitric oxide (NO) immune modulator production, and also down-regulated inducible nitric oxide synthase (iNOS), pro-inflammatory interleukin 6, 1ß and 1α (IL-6, IL-1ß and IL-1α), and tumor necrosis factor α (TNF-α) at both transcript and protein levels, in a concentration dependent manner. Furthermore, it was found that these effects were mediated by nuclear factor kappa B (NF-κB) signaling inhibition. Thus, our findings may contribute towards the development of novel inflammatory drugs.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Chen, L., H. Deng, H. Cui, J. Fang, Z. Zuo, J. Deng, Y. Li, X. Wang, and L. Zhao (2017) Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 9: 7204–7218.
Pahwa, R., A. Goyal, P. Bansal, and I. Jialal (2020) Chronic inflammation, StatPearls [Internet], StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK493173.
Suthar, S. K. and M. Sharma (2015) Recent developments in chimeric NSAIDs as safer anti-inflammatory agents. Med. Res. Rev. 35: 341–407.
Nisar, B., A. Sultan, and S. Rubab (2017) Comparison of medicinally important natural products versus synthetic drugs-a short commentary. Nat. Prod. Chem. Res. 6: 2.
Vane, J. and R. Botting (2003) The mechanism of action of aspirin. Thromb. Res. 110: 255–258.
Rishton, G. M. (2008) Natural Products as a robust source of new drugs and drug leads: past successes and present day issues. Am. J. Cardiol. 101: 43D–49D.
Yang, L., K. S. Wen, X. Ruan, Y. X. Zhao, F. Wei, and Q. Wang (2018) Response of plant secondary metabolites to environmental factors. Molecules. 23: 762.
Paudel, B., H. D. Bhattarai, H. Y. Koh, S. G. Lee, S. J. Han, H. K. Lee, H. Oh, H. W. Shin, and J. H. Yim (2011) Ramalin, a novel nontoxic antioxidant compound from the Antarctic lichen Ramalina terebrata. Phytomedicine. 18: 1285–1290.
Paudel, B., H. D. Bhattarai, H. K. Lee, H. Oh, H. W. Shin, and J. H. Yim (2010) Antibacterial activities of Ramalin, usnic acid and its three derivatives isolated from the Antarctic lichen Ramalina terebrata. Z. Naturforsch. C. J Biosci. 65: 34–38.
Suh, S. S., T. K. Kim, J. E. Kim, J. M. Hong, T. T. T. Nguyen, S. J. Han, U. J. Youn, J. H. Yim, and I. C. Kim (2017) Anticancer activity of ramalin, a secondary metabolite from the antarctic lichen Ramalina terebrata, against colorectal cancer cells. Molecules. 22: 1361.
Jang, Y. J. and S. Pyo (2015) Anti-allergic effect of Ramalin from Ramalina terebrata in TNF-α-stimulated HaCaT and RBL-2H3 cells. Abstracts of EB 2015 Boston. March 28–April 1. Boston, UK.
Chang, Y. H., J. S. Ryu, S. H. Lee, S. G. Park, H. D. Bhattarai, J. H. Yim, and M. H. Jin (2012) Inhibition of melanogenesis by Ramalin from the Antarctic lichen Ramalina terebrata. J. Soc. Cosmet. Sci. Korea. 38: 247–254.
Suh, S. S., S. M. Kim, J. E. Kim, J. M. Hong, S. G. Lee, U. J. Youn, S. J. Han, I. C. Kim, and S. Kim (2017) Anticancer activities of ethanol extract from the Antarctic freshwater microalga, Botryidiopsidaceae sp. BMC Complement Altern. Med. 17: 509.
Suh, S. S., E. J. Yang, S. G. Lee, U. J. Youn, S. J. Han, I. C. Kim, and S. Kim (2017) Bioactivities of ethanol extract from the Antarctic freshwater microalga, Chloromonas sp. Int. J. Med. Sci. 14: 560–569.
Ivanova, V., M. Kolarova, K. Aleksieva, K. J. Dornberger, A. Haertl, U. Moellmann, H. M. Dahse, and N. Chipev (2007) Sanionins: anti-inflammatory and antibacterial agents with weak cytotoxicity from the Antarctic moss Sanionia georgico-uncinata. Prep. Biochem. Biotechnol. 37: 343–352.
Stuehr, D. J. and M. A. Marletta (1985) Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 82: 7738–7742.
Sharma, J. N., A. Al-Omran, and S. S. Parvathy (2007) Role of nitric oxide in inflammatory diseases. Inflammopharmacology. 15: 252–259.
Sautebin, L. (2000) Prostaglandins and nitric oxide as molecular targets for anti-inflammatory therapy. Fitoterapia. 71: S48–S57.
Barnes, P. J. (2006) How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br. J. Pharmacol. 148: 245–254.
Ray, W. A., C. M. Stein, J. R. Daugherty, K. Hall, P. G. Arbogast, and M. R. Griffin (2002) COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet. 360: 1071–1073.
Sholter, D. E. and P. W. Armstrong (2000) Adverse effects of corticosteroids on the cardiovascular system. Can. J. Cardiol. 16: 505–511.
Suissa, S., A. Kezouh, and P. Ernst (2010) Inhaled corticosteroids and the risks of diabetes onset and progression. Am. J. Med. 123: 1001–1006.
Lionakis, M. S. and D. P. Kontoyiannis (2003) Glucocorticoids and invasive fungal infections. Lancet. 362: 1828–1838.
Li, W., H. Yao, X. Niu, Y. Wang, H. Zhang, H. Li, and Q. Mu (2015) Protective effect of δ-amyrone against ethanol-induced gastric ulcer in mice. Immunobiology. 220: 798–806.
Tanaka, T., M. Narazaki, and T. Kishimoto (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 6: a016295.
Chang, R., K. L. Yee, and R. K. Sumbria (2017) Tumor necrosis factor α inhibition for Alzheimer’s disease. J. Cent. Nerv. Syst. Dis. 9: 1179573517709278.
Balkwill, F. (2006) TNF-α in promotion and progression of cancer. Cancer Metastasis. Rev. 25: 409–416.
Madhusudan, S., M. Foster, S. R. Muthuramalingam, J. P. Braybrooke, S. Wilner, K. Kaur, C. Han, S. Hoare, F. Balkwill, D. C. Talbot, T. S. Ganesan, and A. L. Harris (2004) A phase II study of etanercept (Enbrel), a tumor necrosis factor a inhibitor in patients with metastatic breast cancer. Clin. Cancer Res. 10: 6528–6534.
Baldassano, R., C. P. Braegger, J. C. Escher, K. DeWoody, D. F. Hendricks, G. F. Keenan, and H. S. Winter (2003) Infliximab (REMICADE) therapy in the treatment of pediatric Crohn’s disease. Am. J. Gastroenterol. 98: 833–838.
Adams, A. B., M. Kazim, and T. J. A. Lehman (2005) Treatment of orbital myositis with adalimumab (Humira). J. Rheumatol. 32: 1374–1375.
Tak, P. P. and G. S. Firestein (2001) NF-κB: a key role in inflammatory diseases. J. Clin. Invest. 107: 7–11.
Yamamoto, Y. and R. B. Gaynor (2004) IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem. Sci. 29: 72–79.
Acknowledgements
This work was supported by the Korea Polar Research Institute (KOPRI) of the Republic of Korea, under project PE20010.
The authors declare no conflict of interest.
Neither ethical approval nor informed consent was required for this study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Min, S.K., Kim, J.E., Hong, JM. et al. Anti-inflammatory Effects of Lecania gerlachei Extract Collected from the Antarctic King Sejong Island. Biotechnol Bioproc E 25, 543–550 (2020). https://doi.org/10.1007/s12257-019-0371-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12257-019-0371-4